聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 8 分钟 前

Cold Plasma Used In World's First Clinical Surgical Procedure Performed To Selectively Kill Cancer Tumor Cells

周四, 04/16/2015 - 14:15
US Medical Innovations Successfully Completes Innovative Stage 4 Colon Cancer Surgery To Remove Tumor And Eradicate Cancerous Tissue Remnants While Sparing Normal Tissue TAKOMA PARK, Md., April 16, 2015 -- (Healthcare Sales & Marketing Network) -- A su...
Devices, Oncology
US Medical Innovations, Canady Helios, cold plasma, Canady Hybrid Plasma

Ovid Therapeutics Appoints Dr. Jeremy Levin as Chief Executive Officer

周四, 04/16/2015 - 14:07
Dr. Levin joins Ovid Therapeutics to build a world-leading neurology company focused on rare and orphan diseases of the brain NEW YORK--(Healthcare Sales & Marketing Network)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company foc...
Biopharmaceuticals, Neurology, Personnel
Ovid Therapeutics

Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump(R) system

周四, 04/16/2015 - 13:57
ZURICH--(Healthcare Sales & Marketing Network)--Sequana Medical, a Swiss-based medical device company, announced today that it has entered into an agreement with Fresenius Medical Care to commercialize its innovative alfapump system. The alfapump system...
Devices, Distribution
Sequana Medical, Fresenius Medical Care, alfapump, ascites

Peter Falzon Joins Avellino Lab USA as Chief Executive Officer

周三, 04/15/2015 - 15:46
Genetic Test for Refractive Surgery Safety has Screened Nearly a half-million Patients for Granular Corneal Dystrophy with 450 Positive Results MENLO PARK, Calif., April 15, 2015 -- (Healthcare Sales & Marketing Network) -- Avellino Lab USA, developer ...
Diagnostics, Ophthalmology, Personnel
Avellino Lab, Granular Corneal Dystrophy

InspireMD Announces Completion of Sales Restructuring Program

周三, 04/15/2015 - 15:43
BOSTON, April 15, 2015 -- (Healthcare Sales & Marketing Network) -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced the completion of its ...
Devices, Interventional, Cardiology, Distribution
InspireMD, embolic protection, MGuard

Tenax Therapeutics Provides Clinical and Corporate Update

周三, 04/15/2015 - 15:35
Hosted Analyst Day on April 13 with levosimendan clinical and development experts Provided enrollment progress update for ongoing LEVO-CTS and LeoPARDS trials Announced change in fiscal year end MORRISVILLE, N.C.--(Healthcare Sales & Marketing Net...
Biopharmaceuticals, Cardiology
Tenax Therapeutics, levosimendan

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong